Orthopaedic & Neurosurgery Specialists (ONS), a Greenwich, Connecticut-based provider of orthopedic and neurosurgery services with offices in the New York City area, has named Timothy F. Corvino, M.D., its chief executive officer, effective March 1, 2020.
Tim Corvino, M.D., Is new CEO at Greenwich Based ONS

Kohlberg & Company, LLC. (Kohlberg), a private equity firm based in New York, has partnered with ONS on a strategic growth investment. The entities named Dr. Corvino as their new chief executive officer in preparation to expand the company’s footprint through targeted growth with both regional and national partnerships.
Most recently, Dr. Corvino served as chief operating officer of Covenant Physician Partners, Inc. (Covenant), where he prepared the company for the significant growth that occurred during his tenure. Prior to Covenant, he served as president of integrated acute care for U.S. Acute Care Solutions, LLC., the nation’s leading physician-owned provider of integrated acute care services for six million patients annually.
“Tim Corvino’s experience as an executive, as well as a physician, will be a tremendous asset to ONS. As CEO, he will be invaluable in guiding the next chapter in the life of this organization that is centered around growth, while continuing a commitment to providing exceptional patient care,” said Seth R. Miller, M.D., a founding partner of ONS.
“I am thrilled to serve as CEO for ONS, an organization with such a strong history of clinical excellence,” Dr. Corvino told OTW. “With a proven care model and two decades of experience, it is time to leverage ONS’ physician-led ideology. In partnership with the physicians and executive team, we will work to grow our practice regionally by collaborating with like-minded physicians and practices in our area. Over time, we will consider expanding our personalized patient care approach to new communities on a more national scale.”
Founded by physicians in 1998, ONS is a multi-specialty orthopedic and spine group with three locations in Connecticut and New York. The practice’s 26 fellowship-trained physicians provide expertise in the full spectrum of musculoskeletal conditions and injuries, including sports medicine, minimally invasive orthopedic, spine and brain surgery, joint replacement, and trauma. ONS also operates an ambulatory surgery center and offers ancillary services, such as physical therapy, magnetic resonance imaging (MRI), and urgent orthopedic care.
In July 2019, ONS announced a growth capital partnership with Kohlberg. This partnership allowed ONS to expand its extensive offerings of clinical capabilities and ancillary services and serve a broader patient base.
Kohlberg is a leading private equity firm headquartered in Mount Kisco, New York. Since its inception in 1987, Kohlberg has organized eight private equity funds, through which it has raised over $7.5 billion of committed equity capital. Over its 33-year history, Kohlberg has completed 76 platform investments and nearly 200 add-on acquisitions, with an aggregate transaction value of over $15 billion.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.